Maziyar Saberi

Maziyar Saberi is the CSO at January AI. Maziyar has also served as the Vice President, Head of Biological Sciences at Applied Molecular Transport, and the Director, Head of Research at Second Genome, Inc. Maziyar was also the Associate Director, Biology and Head of Pharmacology at NGM Biopharmaceuticals, Inc.

Saberi has led research, clinical development, regulatory affairs, and QA for the development of personalized digital health applications, and gut-targeted nutraceuticals addressing cardiometabolic and immune health. Maziyar has also established discovery platforms for the identification & elucidation of mechanisms of the microbiome- and host-derived peptides, proteins, and metabolites addressing host immunity, cardiometabolic, and liver diseases.

Maziyar Saberi attended the University of California, San Diego School of Medicine and the University of Southern California.

Their manager is Noosheen Hashemi, CEO. Some direct reports include Carlo Armijo - Scientist, Chris Oswald - VP, Nutraceuticals, and JD Ridgeway - VP, Microbiome Division. They work with Mark Woodward - CTO, Mustafa Furniturewala - Technology Advisor, and Radha H. Blackman - Director HR and Operations.